Mitsui Chemicals Launches New Corporate Venture Capital Fund '321Catalyst(TM)' - Mitsui Chemicals, Inc.

27 May 2025 3:11 AM

TOKYO--BUSINESS WIRE--

Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: HASHIMOTO Osamu), a global chemicals manufacturer based in Japan, today announced the launch of its second Corporate Venture Capital Fund ‘321Catalyst™,’ as well as the establishment of a new subsidiary ‘321Catalyst Ventures, Inc.,’ which will manage the fund.
Building on the success of its first fund, ‘321FORCE™,’ launched with Japanese venture capital Global Brain in 2022, 321Catalyst™’s mission will be to accelerate the building of global innovation partnerships and the launching of new products and business. Through the establishment of the new, independent fund in the USA, Mitsui Chemicals is doubling down on global investments in innovative startups that align with its strategic focus. Strong innovation partnerships with its portfolio companies will allow Mitsui Chemicals to launch new businesses ahead of the race. 321Catalyst™ will have a fund size of $60 million and a life of 10 years.

Mitsui Chemicals intends to enhance and strengthen its Basic Strategy of ‘building solutions-based business models’ as manifested in its Long-Term Business Plan, VISION 2030. Consistent with this goal, Mitsui Chemicals will continue investing in startups across the world to escalate the launching of new products and new businesses as well as the transformation of its business portfolio.

Overview of 321Catalyst™, the new Corporate Venture Capital Fund
Registered Name	321Catalyst LP
Address	San Jose, CA, USA
Fund Size	$60 million
Date of Establishment	May 6th, 2025
Fund Life	10 years
Focus Stage	Seed and at all stages beyond
Focus Region	Global (USA, Europe, Asia, etc.)
Focus Industry	All industries including Life & Healthcare, Mobility, ICT, Sustainability, and other new industries
General Partner	321Catalyst Ventures, Inc.
Limited Partner	321Indigo Ventures, Inc. (100% subsidiary of Mitsui Chemicals)

Overview of the new subsidiary acting as the General Partner
Registered Name	321Catalyst Ventures, Inc.
Address	San Jose, CA, USA
Representative	Shunsuke Fujii (President)
Business Overview	Management of Corporate Venture Capital Funds
Date of Establishment	April 10th, 2025
Ownership	100% owned by Mitsui Chemicals America, Inc

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20250526416724/en/

Contact details:

For inquiries about this release, please contact:
Corporate Communications Division, Mitsui Chemicals, Inc.
Tel: +81-3-6880-7500
Inquiry form: https://form.mitsuichemicals.com/corporate/cc_pr_csr_en?param=13

Images: